Amgen Inc.
AMGN
$296.47
$6.182.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.44% | 16.32% | 19.01% | 21.51% | 16.68% |
| Total Other Revenue | 0.86% | -0.37% | 9.22% | 15.53% | 10.28% |
| Total Revenue | 12.88% | 15.56% | 18.57% | 21.25% | 16.37% |
| Cost of Revenue | -0.49% | 7.24% | 16.81% | 53.10% | 36.07% |
| Gross Profit | 18.66% | 18.96% | 19.24% | 9.81% | 9.51% |
| SG&A Expenses | 2.20% | 11.74% | 24.67% | 27.90% | 24.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 286.89% | 9.68% | 50.00% | -169.81% | -64.94% |
| Total Operating Expenses | 5.93% | 12.01% | 21.50% | 26.92% | 26.27% |
| Operating Income | 28.80% | 23.06% | 13.07% | 9.49% | -1.37% |
| Income Before Tax | 110.61% | 53.05% | -41.32% | -46.53% | -61.67% |
| Income Tax Expenses | 103.80% | 23.20% | -54.39% | -62.11% | -67.54% |
| Earnings from Continuing Operations | 111.47% | 57.67% | -39.11% | -44.09% | -60.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 111.47% | 57.67% | -39.11% | -44.09% | -60.77% |
| EBIT | 28.80% | 23.06% | 13.07% | 9.49% | -1.37% |
| EBITDA | 22.20% | 23.18% | 20.61% | 21.58% | 9.65% |
| EPS Basic | 110.67% | 56.99% | -39.39% | -44.30% | -60.83% |
| Normalized Basic EPS | 35.47% | 39.93% | 19.28% | -2.50% | -7.29% |
| EPS Diluted | 110.32% | 56.45% | -39.60% | -44.44% | -60.78% |
| Normalized Diluted EPS | 35.25% | 39.58% | 19.22% | -2.58% | -7.28% |
| Average Basic Shares Outstanding | 0.33% | 0.37% | 0.37% | 0.28% | 0.19% |
| Average Diluted Shares Outstanding | 0.51% | 0.70% | 0.37% | 0.33% | 0.14% |
| Dividend Per Share | 5.71% | 5.67% | 5.63% | 6.60% | 7.62% |
| Payout Ratio | -0.50% | -0.33% | 0.74% | 0.91% | 1.75% |